QIAGEN N.V. announces successful completion of non-U.S. offer involving convertible notes

QIAGEN N.V. launches non-US offering of cash settled convertible notes combined with convertible note hedge and warrant transactions

Ad-hoc announcement pursuant to Art. 17 MAR

QIAGEN launches new DNeasy Plant Pro Kit

QIAGEN expands next-generation sequencing portfolio with oncology and immuno-oncology panels for research using GeneReader NGS System and other platforms 

QIAGEN expands QIAGEN Clinical Insight software to support all major sequencing platforms and assay types

QIAGEN reports results for third quarter and first nine months of 2018

QIAGEN announces winners of 2018 Microbiome Awards competition

QIAGEN’s next-generation QIAstat-Dx system delivers fast, cost-effective diagnosis of gastrointestinal syndromes

QIAGEN launches novel RNA-seq library preparation solutions for next-generation sequencing